Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Artiva Biotherapeutics In...

    NASDAQ: ARTV · Real-Time Price · USD
    1.96
    -0.01 (-0.51%)
    At close: Jun 05, 2025, 3:59 PM
    1.97
    0.69%
    After-hours: Jun 05, 2025, 07:44 PM EDT

    Artiva Biotherapeutics Statistics

    Share Statistics

    Artiva Biotherapeutics has 24.36M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 24.36M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 488

    FTD / Avg. Volume

    n/a
    		 0.15%

    Short Selling Information

    The latest short interest is 1.4M, so 5.73% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.4M

    Short % of Shares Out

    n/a
    		 5.73%

    Short % of Float

    n/a
    		 14.34%

    Short Ratio (days to cover)

    n/a
    		 7.75

    Valuation Ratios

    The PE ratio is -1.94 and the forward PE ratio is -0.71. Artiva Biotherapeutics's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -1.94

    Forward PE

    n/a
    		 -0.71

    PS Ratio

    n/a
    		 452.15

    Forward PS

    n/a
    		 96.7

    PB Ratio

    n/a
    		 0.61

    P/FCF Ratio

    n/a
    		 -2.04

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Artiva Biotherapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.39, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 15.39

    Quick Ratio

    n/a
    		 15.39

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 -0.26

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $2,614.58

    Profits Per Employee

    n/a
    		 $-609,302.08

    Employee Count

    n/a
    		 96

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 5.29, so Artiva Biotherapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 5.29

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 2.3

    200-Day Moving Average

    n/a
    		 7.71

    Relative Strength Index (RSI)

    n/a
    		 42.72

    Average Volume (20 Days)

    n/a
    		 319,917

    Income Statement

    In the last 12 months, Artiva Biotherapeutics had revenue of 251K and earned -58.49M in profits. Earnings per share was -5.2.

    Revenue

    n/a
    		 251K

    Gross Profit

    n/a
    		 251K

    Operating Income

    n/a
    		 -67.28M

    Net Income

    n/a
    		 -58.49M

    EBITDA

    n/a
    		 -64.85M

    EBIT

    n/a
    		 -67.28M

    Earnings Per Share (EPS)

    n/a
    		 -5.2
    Full Income Statement

    Balance Sheet

    The company has 40.23M in cash and 14.35M in debt, giving a net cash position of 25.88M.

    Cash & Cash Equivalents

    n/a
    		 40.23M

    Total Debt

    n/a
    		 14.35M

    Net Cash

    n/a
    		 25.88M

    Retained Earnings

    n/a
    		 -246.68M

    Total Assets

    n/a
    		 209.58M

    Working Capital

    n/a
    		 176.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -55.03M and capital expenditures -642K, giving a free cash flow of -55.67M.

    Operating Cash Flow

    n/a
    		 -55.03M

    Capital Expenditures

    n/a
    		 -642K

    Free Cash Flow

    n/a
    		 -55.67M

    FCF Per Share

    n/a
    		 -4.94
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -26805.58% and -23303.98%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -26805.58%

    Pretax Margin

    n/a
    		 -23303.98%

    Profit Margin

    n/a
    		 -23303.98%

    EBITDA Margin

    n/a
    		 -25837.05%

    EBIT Margin

    n/a
    		 -26805.58%

    FCF Margin

    n/a
    		 -22180.88%

    Dividends & Yields

    ARTV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ARTV is $20, which is 920.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $20

    Price Target Difference

    n/a
    		 920.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.47

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist